Table 3 Predictors of RHI change after 6Â months of antirheumatic treatment in patients with ED
| Â | Unadjusted | Adjusted | ||||
|---|---|---|---|---|---|---|
| Â | Beta | P | 95% CI | Beta | P | 95% CI |
Female gender | 0.492 | 0.011 | 0.118 to 0.865 | 0.621 | 0.004 | 0.220 to 1.022 |
Age | –0.004 | 0.669 | –0.024 to 0.016 | –0.001 | 0.919 | –0.021 to 0.019 |
Anti-TNF ± MTX | –0.505 | 0.008 | –0.866 to –0.143 | –0.448 | 0.032 | –0.855 to –0.041 |
RDD | –0.026 | 0.033 | –0.049 to –0.002 | –0.024 | 0.068 | –0.050 to 0.002 |
PsA | –0.067 | 0.779 | –0.550 to 0.416 | 0.064 | 0.733 | –0.386 to 0.514 |
AS | –0.267 | 0.242 | –0.722 to 0.188 | 0.219 | 0.419 | –0.327 to 0.765 |
CRP | –0.004 | 0.523 | –0.017 to 0.009 |  |  |  |
ESR | –0.002 | 0.771 | –0.017 to 0.013 |  |  |  |
PTX3 | –0.071 | 0.255 | –0.194 to 0.053 |  |  |  |
PGA | 0.008 | 0.160 | –0.003 to 0.019 |  |  |  |
PtGA | –0.001 | 0.824 | –0.008 to 0.006 |  |  |  |
MHAQ | –0.328 | 0.332 | –1.006 to 0.349 |  |  |  |
NSJ | –0.150 | 0.050 | –0.299 to 0.000 |  |  |  |